Miele has acquired a controlling stake in Steelco - a producer of CDS equipment for the hospital and pharma sectors.
The acquisition means that the medical technology division within the Miele Group is set to grow by around one third to approximately € 250 million per annum.
According to the companies the overarching aim is to provide clients with an even broader and more sophisticated range of products – as well as the best possible service, both before and after the sale. The transaction is still subject to approval of the antitrust authorities.
Miele is a leading manufacturer of cleaning, disinfection and sterilisation products for medical and laboratory applications. This includes the project business covering the planning and furnishing of central sterile supply departments (CSSD) in hospitals. “Together with Steelco, Miele can combine its claim to quality and innovation leadership with a significantly broader product portfolio, and hence expand its market position,” says Andreas Barduna, commercial director of Miele Professional business.
Together with domestic appliances, the Miele Group achieved a turnover of € 3.71bn in the last fiscal year and today has 19,400 employees worldwide.
Steelco was founded in 1998 and is based in the town of Riese Pio X in the northern Italian province of Treviso.
The company employs a workforce of around 400, achieved a turnover of € 71m in 2016 and has been recording double-digit growth for many years.
